Quick Takeaways
- Bain Capital Life Sciences Fund, L.P. filed SCHEDULE 13G/A for Pharvaris N.V. Ordinary Shares, Euro 0.12 par value per share (PHVS).
- Disclosed ownership: 2.5%.
- Date of event: 31 Dec 2025.
Bain Capital Life Sciences Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Pharvaris N.V. Ordinary Shares, Euro 0.12 par value per share (PHVS)
- Filing Manager
- Bain Capital Life Sciences Fund, L.P.
- Reporting Manager
- Bain Capital Life Sciences Fund, L.P.
- Symbol
- PHVS
- Shares outstanding
- 65,632,680 shares
- Disclosed Ownership
- 1,640,817 shares
- Ownership
- 2.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:30:03 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Bain Capital Life Sciences Fund, L.P. disclosed 2.5% ownership in Pharvaris N.V. Ordinary Shares, Euro 0.12 par value per share (PHVS) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Fund, L.P. | 2.5% | 1,640,817 | 0 | 1,640,817 | /s/ Ricky Sun | Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC | |
| BCIP Life Sciences Associates, LP | 0.3% | 167,950 | 0 | 167,950 | /s/ Ricky Sun | Ricky Sun, Authorized Signatory of Boylston Coinvestors, LLC | |
| Bain Capital Life Sciences Opportunities III, LP | 1.5% | 993,314 | 0 | 993,314 | /s/ Ricky Sun | Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC |